Antibacterials for anthrax prophylaxis: adverse events

被引:0
|
作者
机构
关键词
Public Health; Adverse Event; Abdominal Pain; Disease Control; Metropolitan Area;
D O I
10.2165/00128415-200208840-00001
中图分类号
学科分类号
摘要
引用
收藏
页码:2 / 2
相关论文
共 50 条
  • [41] New prophylaxis methods for adverse events of uterine compression sutures: removing compression threads
    Matsubara, Shigeki
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2014, 93 (10) : 1069 - 1070
  • [42] Neuropsychiatric adverse events during prophylaxis against malaria by using mefloquine before traveling
    Al-Amer, Osama
    ANNALS OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2015, 8 (05) : 159 - 163
  • [43] Adverse events in patients treated with attenuated androgens for the long term prophylaxis of hereditary angioedema
    Lleonart, R.
    Andres, B.
    Vallano, A.
    Girbau, A.
    Corominas, M.
    ALLERGY, 2015, 70 : 257 - 257
  • [44] Cost of fremanezumab, erenumab, galcanezumab and onabotulinumtoxinA associated adverse events, for migraine prophylaxis in Spain
    Irimia, Pablo
    Santos-Lasaosa, Sonia
    Garcia Bujalance, Laura
    Ramos Pinazo, Luis
    Rubio-Rodriguez, Dario
    Rubio-Terres, Carlos
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (02) : 285 - 297
  • [45] Incidence of Pneumocystis jirovecii and Adverse Events Associated With Pneumocystis Prophylaxis in Children Receiving Glucocorticoids
    Basiaga, Matthew L.
    Ross, Michelle E.
    Gerber, Jeffrey S.
    Ogdie, Alexis
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2018, 7 (04) : 283 - 289
  • [46] Clinical management, monitoring, and prophylaxis of adverse events of special interest associated with datopotamab deruxtecan
    Heist, Rebecca S.
    Sands, Jacob
    Bardia, Aditya
    Shimizu, Toshio
    Lisberg, Aaron
    Krop, Ian
    Yamamoto, Noboru
    Kogawa, Takahiro
    Al-Hashimi, Saba
    Fung, Simon S. M.
    Galor, Anat
    Pisetzky, Francesca
    Basak, Priyanka
    Lau, Cindy
    Meric-Bernstam, Funda
    CANCER TREATMENT REVIEWS, 2024, 125
  • [47] Adverse events and development of tuberculosis after 4 months of rifampicin prophylaxis in a tuberculosis outbreak
    Lee, S. H.
    Yim, J. -J.
    Kim, H. J.
    Shim, T. S.
    Seo, H. S.
    Cho, Y. S.
    Lee, H. -K.
    Lee, Y. M.
    Lee, E. J.
    Lew, W. J.
    EPIDEMIOLOGY AND INFECTION, 2012, 140 (06): : 1028 - 1035
  • [48] Prophylaxis and treatment of dermatologic adverse events from epidermal growth factor receptor inhibitors
    Wu, Peggy A.
    Balagula, Yevgeniy
    Lacouture, Mario E.
    Anadkat, Milan J.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (04) : 343 - 351
  • [49] Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: A focus on neuropsychiatric adverse events
    van Riemsdijk, MM
    Sturkenboom, MCJM
    Ditters, JM
    Ligthelm, RJ
    Overbosch, D
    Stricker, BHC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (03) : 294 - 301
  • [50] Anthrax events hike scientific interest
    Ember, L
    CHEMICAL & ENGINEERING NEWS, 1998, 76 (09) : 12 - 12